Arphra/Issuer/RVMD

RVMD

Revolution Medicines, Inc.

HealthcareBiotechnologyUSUSD

$152.33

LiveJun 02, 2026

AI Brief

Market cap

$32.38B

52w range

34.00 – 166.50

P / E

—

EPS

—

Volume

2.64M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Revolution Medicines, Inc.’s valuation

Multiples · RVMD

Historical valuation

TTM/LTM-basis multiples with σ-banded history. Fair value below uses current denominator and FY2027 consensus.

1 year 3 years 5 years

The key_metrics_ttm loader hasn't indexed enough history for RVMD to build a Z-scored multiples view yet. Try a shorter period or check back after the next daily run.

P/E (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / EBITDA (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / Sales (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

Dividend yield (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

No peer set loaded for RVMD. Run the peers loader to populate the comparison.

Pro

Multiples

Valuation multiples and peer comparisons are included with Pro.

Upgrade to Pro